The nervous system medicine market in Japan continues its growth trajectory from 2024 to 2028, with values escalating from 9.87 billion USD PPP to 10.3 billion USD PPP. In comparison to 2023, the market is anticipated to expand at an annual average increase of around 1.1%. This trend indicates steady growth, fueled by both rising healthcare needs and technological advancements in treatment options.

Future trends to watch for:

Advancements in personalized medicine and related technologies.
Increasing prevalence of neurological disorders, potentially boosting market growth further.
Potential regulatory changes impacting drug approval and sales.